Baselight
Sign In
YesterdayJun 12Jun 11Jun 10Jun 9Jun 8Jun 7Jun 6Jun 5Jun 4Jun 3Jun 2Jun 1May 31May 30May 29May 28May 27May 26May 25May 24May 23May 22May 21May 20May 19May 18May 17May 16May 15May 14May 13May 12May 11May 10May 9May 8May 7May 6May 5May 4May 3May 2May 1Apr 30Apr 29Apr 28Apr 27Apr 26Apr 24Apr 22Apr 21Apr 20Apr 19Apr 18Apr 17

Stocks

June 6, 2026

Anomaly01STOCKS

BioCardia volume jumps 463x on FDA heart therapy support

  • BioCardia shares surged under massive volume after receiving positive regulatory feedback from the FDA for its heart failure cell therapy.
  • Trading volume spiked to 150,347,798 shares, representing a 463-fold increase over its 20-day average of 324,426 shares.
  • This regulatory milestone provides a clear path toward premarket approval, significantly boosting investor confidence in the clinical study.
BioCardia volume jumps 463x on FDA heart therapy support
Anomaly02STOCKS

Sleep Number volume spikes 112x following bankruptcy preparation reports

  • Sleep Number experienced extreme price volatility and massive trading volume following reports of potential bankruptcy preparation.
  • Trading volume exploded to 303,435,800 shares, which is 112 times its 20-day average volume of 2,710,120 shares, while the stock rose 37.1% to close at $0.48.
  • The extreme volatility and high volume indicate intense speculative trading as investors react to restructuring risks and market share threats.
Sleep Number volume spikes 112x following bankruptcy preparation reports
Outlier03STOCKS

Nuwellis drops 60.6% on a 293x volume spike after pricing $6M offering

  • Nuwellis shares collapsed to near-record lows on heavy volume after the medical device manufacturer announced a dilutive public offering.
  • The stock fell 60.6% to close at $0.17 on a volume of 48,653,700 shares, which is 293 times its 20-day average of 165,640 shares.
  • This massive dilution highlights the high cost of capital for micro-cap medical technology companies seeking to fund commercialization.
Nuwellis drops 60.6% on a 293x volume spike after pricing $6M offering
Outlier04STOCKS

Nyxoah SA collapses 49.7% following a discounted stock offering

  • Nyxoah SA shares fell by nearly half after the medical technology company priced a new stock offering at a steep discount.
  • The stock fell 49.7% to close at $1.45 on a volume of 2,440,000 shares, which is 62.6 times its 20-day average of 38,969 shares.
  • The capital raise dilutes existing shareholders but secures the necessary funding to support the U.S. commercial rollout of its sleep apnea system.
Nyxoah SA collapses 49.7% following a discounted stock offering
Trend Shift05STOCKS

Zscaler receives 43 upward EPS revisions in 7 days; Q3 earnings beat drives consensus estimate higher

  • Zscaler received 43 upward EPS revisions for the current fiscal year in the past 7 days, with only 1 downward revision.
  • The current quarter consensus EPS estimate climbed 5.3% from $1.03468 to $1.09001 over the same period.
  • The revisions follow the company's fiscal Q3 earnings report, which beat expectations and included raised full-year guidance.
Zscaler receives 43 upward EPS revisions in 7 days; Q3 earnings beat drives consensus estimate higher
Outlier06STOCKS

Cypherpunk Technologies falls 47.1% on Zcash privacy bug concerns

  • Cypherpunk Technologies shares fell sharply following reports of a newly discovered privacy bug in the Zcash cryptocurrency network.
  • The stock fell 47.1% to close at $0.5188 on a heavy volume of 28,383,557 shares, down from its previous close of $0.9814.
  • As an investment firm focused on privacy technologies, Cypherpunk's valuation is highly sensitive to technical disruptions in its core asset holdings.
Cypherpunk Technologies falls 47.1% on Zcash privacy bug concerns

Share link

Anyone who has the link will be able to view this.